Wisp’s newest prescription duo tackles skin aging and low libido at once

Wisp has made its name providing fast, accessible telehealth on a direct-to-consumer model. Today, the brand is expanding its longevity offerings for women’s health with two prescriptions that target common signs of aging: skin concerns and low sexual desire. Both additions build on the Longevity and Aging category Wisp launched earlier this year, joining an existing lineup of longevity-focused products like glutathione, NAD+, and low-dose naltrexone.

What’s in the lineup

GHK-Cu topical cream at 0.5% concentration is designed to replenish a peptide that naturally declines with age. As GHK-Cu levels drop, skin tends to lose firmness and smoothness. Applied topically, it’s meant to work on that decline directly, supporting the skin’s own repair processes rather than sitting on top of it the way a standard moisturizer does.

The second product in the launch, Bremelanotide (PT-141), is a nasal spray aimed at supporting sexual desire. Wisp is known for its spray format, and for many users, it can be a much more convenient option. Most existing PT-141 options come as injectables, so a spray lowers the barrier for women who might otherwise skip treatment altogether.

Together, the two treat symptoms that rarely get grouped under “aging,” even though both are tied to the same hormonal shifts happening underneath.

The massive popularity of peptides has cemented them in most people’s minds as weight loss drugs. But, as they get more clinical attention, it’s becoming clear they’re relevant to a much wider range of functions, and skin repair and sexual desire are two of them. Grouping them into a lineup like this one is part of what’s shifting the conversation, treating skin repair and sexual desire not just as women’s health concerns, but as legitimate longevity concerns worth addressing.